Natural polysaccharides platforms for oral controlled release of ketoprofen lysine salt

被引:13
|
作者
Cerciello, Andrea [1 ,2 ]
Auriemma, Giulia [1 ]
Del Gaudio, Pasquale [1 ]
Cantarini, Marco [3 ]
Aquino, Rita P. [1 ]
机构
[1] Univ Salerno, Dept Pharm, Via Giovanni Paolo 2 132, I-84084 Fisciano, SA, Italy
[2] Univ Salerno, PhD Program Drug Discovery & Dev, Fisciano, SA, Italy
[3] Dompe Farmaceut SPA, R&D Dept, Laquila, Italy
关键词
Ketoprofen lysine salt; oral controlled release platforms; polysaccharides based beads; prilling; xerogel; DRUG-DELIVERY; ALGINATE BEADS; HYDROGEL BEADS; PECTIN; FORMULATIONS; DESIGN; EFFICACY;
D O I
10.1080/03639045.2016.1195401
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Context: Ketoprofen lysinate (KL) is one of the most widely used non-steroidal anti-inflammatory drugs in the symptomatic treatment of some chronic inflammatory diseases. Compared to ketoprofen, KL shows better pharmacokinetics and tolerability. However, due to its short half-life of 1-2h, a multiple dose regimen is required for oral administration. Thus, the present work deals with its encapsulation in a hydrogel-based system by prilling in order to prolong its activity.Objective: In this paper, we propose alginate and pectin as carriers and release tailoring agent for the development of hydrogel-based beads for KL retarded and sustained release.Materials and methods: Beads were produced by a Nisco Encapsulator (R) using alginate or pectin. Operative variables were optimized to produce beads with desired morphology and size. Solid state properties were analyzed by SEM and DSC. Drug release performance was studied by Pharmacopeia pH-change assay to simulate gastrointestinal environment.Results and discussion: Prilling technique was successfully used to encapsulate high soluble drugs as KL in polysaccharides-based hydrogels. Pectin proved to be a proper polymer able to encapsulate ketoprofen lysine salt. Formulation (F8) showed good morphological properties and size, high drug content (15.6%) and encapsulation efficiency (93.5%) and promising drug release profiles. Hosting F8 in an acid-resistant capsule (DR((R))caps) a delivery platform has been developed to control KL release in a delayed (90min lag time) and prolonged way (270min complete release).Conclusion: The platform may be proposed as potentially useful in the oral administration of NSAIDs in chronic inflammatory diseases affected by circadian rhythm.
引用
收藏
页码:2063 / 2069
页数:7
相关论文
共 50 条
  • [21] PHARMACOKINETIC COMPARISON OF 320 MG OF 2 DIFFERENT ORAL CAPSULE FORMULATIONS OF KETOPROFEN-LYSINE SALT IN HEALTHY-VOLUNTEERS
    FINCATO, G
    FERRARI, MP
    SCAPINELLI, AC
    ADVANCES IN THERAPY, 1993, 10 (04) : 182 - 188
  • [22] Clinical use of ketoprofen lysine salt: a reappraisal in adolescents with acute respiratory infections
    Marseglia, Gian Luigi
    Ciprandi, Giorgio
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (06) : 76 - 82
  • [23] INTER-SUBJECT VARIATION IN ORAL ABSORPTION OF KETOPROFEN FROM CONTROLLED-RELEASE GRANULES IN RABBITS
    KOHRI, N
    IWASA, K
    KURIHARA, J
    MIYAZAKI, K
    ARITA, T
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 49 (03) : 213 - 221
  • [24] Structural homeostasis and controlled release for anthocyanin in oral film via sulfated polysaccharides complexation
    Bao, Yiwen
    Yang, Xi
    Li, Jiaxin
    Li, Zhiying
    Cheng, Zhen
    Wang, Mingshuang
    Li, Zhongxia
    Si, Xu
    Li, Bin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 256
  • [25] Potential of lactic acid bacteria derived polysaccharides for the delivery and controlled release of oral probiotics
    Liao, Ning
    Pang, Bing
    Jin, Han
    Xu, Xiaoguang
    Yan, Lu
    Li, Huixin
    Shao, Dongyan
    Shi, Junling
    JOURNAL OF CONTROLLED RELEASE, 2020, 323 : 110 - 124
  • [26] PHARMACOKINETIC PROFILE OF CONTROLLED RELEASE KETOPROFEN IN ELDERLY PATIENTS
    DENNIS, MJ
    FRENCH, PC
    CROME, P
    BABIKER, M
    SHILLINGFORD, J
    HOPKINS, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (06) : 567 - 573
  • [27] PHARMACOKINETIC PROFILE OF CONTROLLED RELEASE KETOPROFEN IN ELDERLY PATIENTS
    DENNIS, MJ
    FRENCH, PC
    CROME, P
    BABIKER, MM
    SHILLINGFORD, J
    HOPKINS, R
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 100 - 100
  • [28] Efficacy of ketoprofen lysine salt and paracetamol/acetaminophen to reduce pain during rapid maxillary expansion: A randomized controlled clinical trial
    Cossellu, Gianguido
    Lanteri, Valentina
    Lione, Roberta
    Ugolini, Alessandro
    Gaffuri, Francesca
    Cozza, Paola
    Farronato, Marco
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2019, 29 (01) : 58 - 65
  • [29] Polysaccharides in controlled release formulations.
    BeMiller, JN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U332 - U332
  • [30] A CONTROLLED TRIAL OF ORAL KETOPROFEN IN CHRONIC CANCER PAIN
    STAMBAUGH, JE
    MCADAMS, J
    LAROUCHE, SJ
    VAVRA, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 231 - 231